Stability of Cytarabine Admixtures

Cytarabine 혼합조제액의 안정성 연구

  • Jang, Seung Yeon (Division of Pharmaceutical Services, Samsung Medical Center and Clinical Pharmacology Research Center) ;
  • Cha, Hee Soo (Division of Pharmaceutical Services, Samsung Medical Center and Clinical Pharmacology Research Center) ;
  • Kim, Myung Min (Samsung Biomedical Research Institute) ;
  • Lee, Young Mee (Division of Pharmaceutical Services, Samsung Medical Center and Clinical Pharmacology Research Center) ;
  • Sohn, Kie Ho (Division of Pharmaceutical Services, Samsung Medical Center and Clinical Pharmacology Research Center) ;
  • Choi, Kyung Eob (Division of Pharmaceutical Services, Samsung Medical Center and Clinical Pharmacology Research Center)
  • Published : 1998.05.01

Abstract

The stability of cytarabine (manufactured by two pharmaceutical companies) in intravenous admixture and in plastic syringe was investigated. The admixures containing cytarabine 0.35, 8.6, and 17.1 mg/ml in $0.9\%\;NaCl\;or\;5\%$ D5W were placed in PVC bags or glass bottles, and the reconstituted cytarabine (50 mg/ml) was placed in plastic syringe. One ml aliquots were withdrawn immediately after each preparation and stored at $4^{\circ}C\;or\;24^{\circ}C$ for 1, 2, 4, 6, 8, 10, and 14 days unprotected from light. Each sample was tested for pH and visually inspected for precipitation and change in color. Cytarabine concentrations were measured using high-performance liquid chromatography. Neither precipitation nor change in color was noted, and there were no change in pH during 14 days of testing. The changes in cytarabine concentrations were less than $10\%$. In conclusion, cytarabine in IV admixture or plastic syringe was stable for at least 14 days at $4^{\circ}C\;and\;24^{\circ}C.$(Kor. J. Clin. Pharm. 1998; 8(1): 59-67)

Keywords